source
- Congressional panel warns US rare-disease lead is eroding and calls for supportive policiesA Congressional advisory panel has urged the U.S. government to adopt policies that would help rare disease drug development, including a finalized FDA platform designation and the use of novel tri…
- AI data emerges as a key hurdle in biopharma partnership dealsAs drug discovery becomes more intricate, the data used to train AI models is turning into a valuable asset in biopharma transactions. Companies are now negotiating not just drug candidates but the…